These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32783473)

  • 1. Use of the Interoperable Artificial Pancreas System for Type 1 Diabetes Management During Psychological Stress.
    Pinsker JE; Deshpande S; McCrady-Spitzer S; Church MM; Kaur RJ; Perez J; Desjardins D; Piper M; Reid C; Doyle FJ; Kudva YC; Dassau E
    J Diabetes Sci Technol; 2021 Jan; 15(1):184-185. PubMed ID: 32783473
    [No Abstract]   [Full Text] [Related]  

  • 2. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
    Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
    J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What is the current state of the artificial pancreas in diabetes care?].
    Dimou M; Laimer M; Stettler C; Bally L
    Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.
    Abitbol A; Rabasa-Lhoret R; Messier V; Legault L; Smaoui M; Cohen N; Haidar A
    Diabetes Technol Ther; 2018 Mar; 20(3):189-196. PubMed ID: 29393675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated Insulin Dosing Systems or Automated Insulin Delivery Systems? It is Time for Consistency.
    Klonoff DC; Shang T; Zhang J
    J Diabetes Sci Technol; 2021 Mar; 15(2):211-213. PubMed ID: 33650456
    [No Abstract]   [Full Text] [Related]  

  • 6. Development and Future of Automated Insulin Delivery (AID) Systems.
    Garg SK; McVean JJ
    Diabetes Technol Ther; 2024 Mar; 26(S3):1-6. PubMed ID: 38377322
    [No Abstract]   [Full Text] [Related]  

  • 7. Open-source automated insulin delivery in type 1 diabetes-the evidence is out there.
    Hussain S; Lal RA; Braune K
    Lancet Diabetes Endocrinol; 2022 Dec; 10(12):835-836. PubMed ID: 36244346
    [No Abstract]   [Full Text] [Related]  

  • 8. Do-It-Yourself Automated Insulin Delivery: A Position Statement.
    ; Halperin IJ; Chambers A; Covello L; Farnsworth K; Morrison AE; Schuklenk U; Witteman HO; Senior P; ; Bajaj HS; Barnes T; Gilbert J; Honshorst K; Kim J; Lewis J; MacDonald B; Mackay D; Mansell K; Rabi D; Senior P; Sherifali D
    Can J Diabetes; 2023 Jul; 47(5):381-388. PubMed ID: 37532365
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Ambulatory Glucose Profile in Patients With Type 1 Diabetes Mellitus After Switching From Sensor-Augmented Insulin Pump Therapy to a Do-It-Yourself Artificial Pancreas System: A Retrospective Data Analysis of Real-World Data.
    Müller-Korbsch M; Frühwald L; Kietaibl A
    J Diabetes Sci Technol; 2022 Nov; 16(6):1577-1579. PubMed ID: 35915931
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantifying Input Behaviors That Influence Clinical Outcomes in Diabetes and Other Chronic Illnesses.
    Lewis DM
    J Diabetes Sci Technol; 2022 May; 16(3):786-787. PubMed ID: 34971322
    [No Abstract]   [Full Text] [Related]  

  • 12. Type 1 diabetes: NICE recommends new "artificial pancreas" technology.
    Iacobucci G
    BMJ; 2023 Jan; 380():55. PubMed ID: 36627118
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of an Artificial Pancreas with Enhanced Model Predictive Control and a Glucose Prediction Trust Index with Unannounced Exercise.
    Pinsker JE; Laguna Sanz AJ; Lee JB; Church MM; Andre C; Lindsey LE; Doyle FJ; Dassau E
    Diabetes Technol Ther; 2018 Jul; 20(7):455-464. PubMed ID: 29958023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large Treatment Effects With Automated Insulin Delivery System.
    Slomski A
    JAMA; 2022 Oct; 328(16):1581-1582. PubMed ID: 36282258
    [No Abstract]   [Full Text] [Related]  

  • 15. Emerging Technologies for Diabetes Care.
    Bailey TS; Walsh J; Stone JY
    Diabetes Technol Ther; 2018 Jun; 20(S2):S278-S284. PubMed ID: 29916738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who needs an artificial pancreas? (？).
    Winikoff J; Drexler A
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review on artificial pancreas and regenerative medicine used in the management of Type 1 diabetes mellitus.
    Sachdeva P; M AR; Shukla R; Sahani A
    J Med Eng Technol; 2022 Nov; 46(8):693-702. PubMed ID: 35801984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated blood glucose control in type 1 diabetes: A review of progress and challenges.
    Bertachi A; Ramkissoon CM; Bondia J; Vehí J
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):172-181. PubMed ID: 29279252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial Pancreas Improved Outcomes in Children With Type 1 Diabetes.
    Harris E
    JAMA; 2023 Apr; 329(15):1249. PubMed ID: 36988977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.